Regulation of proliferation, survival, differentiation, and activation by the Signaling Platform for SHP-1 phosphatase

Advances in Biological Regulation

Volumn 52, Issue 1, 2012, Pages 7-15

  Kawakami, Toshiaki ^a   Xiao, Wenbin ^a,b   Yasudo, Hiroki ^a   Kawakami, Yuko ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865642838     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2011.09.003     Document Type: Review

References (50)

1. Abramson J., Rozenblum G., Pecht I. Dok protein family members are involved in signaling mediated by the type 1 Fcε receptor. Eur J Immunol 2003, 33:85-91.
2. Abu-Dayyeh I., Ralph B., Grayfer L., Belosevic M., Cousineau B., Oliver M. Identification of key cytosolic kinases containing evolutionarily conserved kinase tyrosine-based inhibitory motifs (KTIMs). Dev Comp Immunol 2010, 34:481-484.
3. Abu-Dayyeh I., Shio M.T., Sato S., Akira S., Cousineau B., Olivier M. Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif. PLoS Negl Trop Dis 2008, 2:e305.
4. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985, 318:533-538.
5. Alonso A., Sasin J., Bottini N., Friedberg I., Osterman A., Godzik A., et al. Protein tyrosine phosphatases in the human genome. Cell 2004, 117:699-711.
6. Bach T.L., Chen Q.M., Kerr W.T., Wang Y., Lian L., Choi J.K., et al. Phospholipase Cβ is critical for T cell chemotaxis. J Immunol 2007, 179:2223-2227.
7. Barnstein B.O., Li G., Wang Z., Kennedy S., Chalfant C., Nakajima H., et al. Stat5 expression is required for IgE-mediated mast cell function. J Immunol 2006, 177:3421-3426.
8. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361:315-325.
9. Bhattacharya R., Kwon J., Li X., Wang E., Patra S., Bida J.P., et al. Distinct role of PLCβ3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci 2009, 122:1025-1034.
10. Boxer L.M., Dang C.V. Translocations involving c-myc and c-myc function. Oncogene 2001, 20:5595-5610.
11. Brunet A., Pouyssegur J. Mammalian MAP kinase modules: how to transduce specific signals. Essays Biochem 1997, 32:1-16.
12. Burack W.R., Shaw A.S. Signal transduction: hanging on a scaffold. Curr Opin Cell Biol 2000, 12:211-216.
13. Camps M., Carozzi A., Schnabel P., Scheer A., Parker P.J., Gierschik P. Isozyme-selective stimulation of phospholipase C-β2 by G protein βγ-subunits. Nature 1992, 360:684-686.
14. Eiseman E., Bolen J.B. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 1992, 355:78-80.
15. Emanuel P.D. Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia. Leukemia 2008, 22:1335-1342.
16. Emanuel P.D., Bates L.J., Castleberry R.P., Gualtieri R.J., Zuckerman K.S. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991, 77:925-929.
17. Frank C., Burkhardt C., Imhof D., Ringel J., Zschornig O., Wieligmann K., et al. Effective dephosphorylation of Src substrates by SHP-1. J Biol Chem 2004, 279:11375-11383.
18. Gouilleux F., Wakao H., Mundt M., Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 1994, 13:4361-4369.
19. Hernandez-Hansen V., Smith A.J., Surviladze Z., Chigaev A., Mazel T., Kalesnikoff J., et al. Dysregulated FcεRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. J Immunol 2004, 173:100-112.
20. Hibbs M.L., Harder K.W., Armes J., Kountouri N., Quilici C., Casagranda F., et al. Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med 2002, 196:1593-1604.
21. Inagaki N., Goto S., Yamasaki M., Nagai H., Koda A. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear. Int Arch Allergy Appl Immunol 1986, 80:285-290.
22. Katz A., Wu D., Simon M.I. Subunits βγ of heterotrimeric G protein activate β2 isoform of phospholipase C. Nature 1992, 360:686-689.
23. Kawakami T., Galli S.J. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002, 2:773-786.
24. Kimura T., Zhang J., Sagawa K., Sakaguchi K., Appella E., Siraganian R.P. Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor. J Immunol 1997, 159:4426-4434.
25. Lee S.B., Shin S.H., Hepler J.R., Gilman A.G., Rhee S.G. Activation of phospholipase C-β2 mutants by G protein αq and βγ subunits. J Biol Chem 1993, 268:25952-25957.
26. Li Z., Jiang H., Xie W., Zhang Z., Smrcka A.V., Wu D. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science 2000, 287:1046-1049.
27. Lorenz U. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev 2009, 228:342-359.
28. Lorenz U., Ravichandran K.S., Pei D., Walsh C.T., Burakoff S.J., Neel B.G. Lck-dependent tyrosyl phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells. Mol Cell Biol 1994, 14:1824-1834.
29. Manning G., Whyte D., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
30. Mashima R., Hishida Y., Tezuka T., Yamanashi Y. The roles of Dok family adapters in immunoreceptor signaling. Immunol Rev 2009, 232:273-285.
31. McKenzie R.C., Jones C.L., Tosi I., Caesar J.A., Whittaker S.J., Mitchell T.J. Constitutive activation of STAT3 in Sezary syndrome is independent of SHP-1. Leukemia 2011, 10.1038/leu.2011.198.
32. Nakamura K., Kouro T., Kincade P.W., Malykhin A., Maeda K., Coggeshall K.M. Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrow. J Exp Med 2004, 199:243-254.
33. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992, 258:607-614.
34. Poole A.W., Jones M.L. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell Signal 2005, 17:1323-1332.
35. Rauh M.J., Ho V., Pereira C., Sham A., Sly L.M., Lam V., et al. SHIP represses the generation of alternatively activated macrophages. Imm unity 2005, 23:361-374.
36. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 2001, 70:281-312.
37. Salojin K., Oravecz T. Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes. J Leukoc Biol 2007, 81:860-869.
38. Tartaglia M., Niemeyer C.M., Shannon K.M., Loh M.L. SHP-2 and myeloid malignancies. Curr Opin Hematol 2004, 11:44-50.
39. Tsui F.W., Martin A., Wang J., Tsui H.W. Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1. Immunol Res 2006, 35:127-136.
40. Tsui H.W., Siminovitch K.A., de Souza L., Tsui F.W. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet 1993, 4:124-129.
41. Uchida T., Matozaki T., Noguchi T., Yamao T., Horita K., Suzuki T., et al. Insulin stimulates the phosphorylation of Tyr538 and the catalytic activity of PTP1C, a protein tyrosine phosphatase with Src homology-2 domains. J Biol Chem 1994, 269:12220-12228.
42. Waldo G.L., Ricks T.K., Hicks S.N., Cheever M.L., Kawano T., Tsuboi K., et al. Kinetic scaffolding mediated by a phospholipase C-β and Gq signaling complex. Science 2010, 330:974-980.
43. Wershil B.K., Wang Z.S., Gordon J.R., Galli S.J. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest 1991, 87:446-453.
44. Xiao W., Ando T., Wang H.Y., Kawakami Y., Kawakami T. Lyn- and PLC-β3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease. Blood 2010, 116:6003-6013.
45. Xiao W., Hong H., Kawakami Y., Kato Y., Wu D., Yasudo H., et al. Tumor suppression by phospholipase C-β3 via SHP-1-mediated dephosphorylation of Stat5. Cancer Cell 2009, 16:161-171.
46. Xiao W., Hong H., Kawakami Y., Lowell C.A., Kawakami T. Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5. J Clin Invest 2008, 118:924-934.
47. Xiao W., Kashiwakura J., Hong H., Yasudo H., Ando T., Maeda-Yamamoto M., et al. Phospholipase C-β3 regulates FcεRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1. Immunity 2011, 34:893-904.
48. Xiao W., Nishimoto H., Hong H., Kitaura J., Nunomura S., Maeda-Yamamoto M., et al. Positive and negative regulation of mast cell activation by Lyn via the FcεRI. J Immunol 2005, 175:6885-6892.
49. Yang J., Liu L., He D., Song X., Liang X., Zhao Z.J., et al. Crystal structure of human protein-tyrosine phosphatase SHP-1. J Biol Chem 2003, 278:6516-6520.
50. Yasudo H., Ando T., Xiao W., Kawakami Y., Kawakami T. Short Stat5-interacting peptide derived from phospholipase C-beta3 inhibits hematopoietic cell proliferation and myeloid differentiation. PLoS ONE 2011, 6:e24995.